Massierer Daniela, Sapir-Pichhadze Ruth, Bouchard Vanessa, Dasgupta Kaberi, Fernandez Nicolas, da Costa Deborah, Ahmed Sara, Fortin Marie-Chantal, Langevin Rosalie, Mayo Nancy, Janaudis-Ferreira Tania
School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada.
Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
JMIR Res Protoc. 2019 Jun 24;8(6):e13420. doi: 10.2196/13420.
Although it is well known that compared with dialysis, kidney transplantation improves the quality of life (QoL) of patients with end-stage renal disease, posttransplant recovery of physical health and other aspects of QoL remain well below age- and sex-matched norms. In addition, most transplant recipients are not physically active even years after the transplant and face several barriers to engaging in physical activity (PA). This is of concern as low levels of PA in transplant recipients has been associated with increased risk of mortality and poor graft function. Optimization of QoL needs a team approach involving the patients and the members of the health care team. While members of the health care team are focused on optimizing the biological responses to transplant, patients may have few or no tools at their disposal to engage in behaviors that optimize QoL. To accomplish the need of supporting these patients in the self-management of their condition and to facilitate engagement with PA, new tools tailored to this population are required.
The aim of this protocol study is to develop a Web-based, patient-centered self-management intervention to promote a healthy lifestyle, increase daily PA, and improve QoL in kidney transplant recipients.
We will use the Obesity-Related Behavioral Intervention Trials model for developing behavioral treatments for chronic diseases to guide the proposed project. We will follow a modified version of the iterative 10-step process that was used to develop educational material for people with multiple sclerosis. The development of the intervention will occur in partnership with patients and a multidisciplinary team of clinicians and researchers. A comprehensive needs assessment including data from our pilot study, literature review, and focus groups will be conducted. The focus groups will be conducted with 6 to 10 participants for each type of stakeholders: patients and professional experts to identify areas of concerns of kidney transplant recipients that are appropriate to address through self-management. The areas of concern identified through the assessment needs will be included in the website.
This study has received funding from the Kidney Foundation of Canada for 2 years (2018-2020) and was recently granted ethics approval. Investigators have begun conducting the needs assessment described in step 1 of the study. The study is expected to be completed by the end of 2020.
This will be the first comprehensive, evidence- and experience-based self-management program for kidney transplant recipients. Once the intervention is developed, we anticipate improvements in patient experience, shared decision making, daily PA, QoL, and, in future studies, improvements in health outcomes and demonstrations of cost savings in posttransplant care.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/13420.
尽管众所周知,与透析相比,肾移植可改善终末期肾病患者的生活质量(QoL),但移植后身体健康及生活质量其他方面的恢复仍远低于年龄和性别匹配的标准。此外,大多数移植受者即使在移植多年后身体也不活跃,且在参与体育活动(PA)方面面临诸多障碍。这令人担忧,因为移植受者体育活动水平低与死亡风险增加及移植肾功能不佳有关。优化生活质量需要患者和医疗团队成员共同参与的团队方法。虽然医疗团队成员专注于优化对移植的生物学反应,但患者可能几乎没有或根本没有可用于采取优化生活质量行为的工具。为满足支持这些患者自我管理病情以及促进其参与体育活动的需求,需要针对该人群量身定制的新工具。
本方案研究的目的是开发一种基于网络、以患者为中心的自我管理干预措施,以促进健康的生活方式,增加日常体育活动,并改善肾移植受者的生活质量。
我们将使用肥胖相关行为干预试验模型来开发慢性病行为治疗方法,以指导本项目。我们将遵循用于为多发性硬化症患者开发教育材料的迭代10步流程的修改版本。干预措施的开发将与患者以及临床医生和研究人员的多学科团队合作进行。将进行全面的需求评估,包括来自我们试点研究、文献综述和焦点小组的数据。将针对每种利益相关者类型(患者和专业专家)组织6至10名参与者的焦点小组,以确定肾移植受者适合通过自我管理解决的关注领域。通过评估需求确定的关注领域将纳入网站。
本研究已获得加拿大肾脏基金会为期两年(2018 - 2020年)的资助,最近已获得伦理批准。研究人员已开始进行研究第1步中描述的需求评估。预计该研究将于2020年底完成。
这将是首个针对肾移植受者的全面、基于证据和经验的自我管理项目。一旦开发出干预措施,我们预计患者体验、共同决策、日常体育活动、生活质量将得到改善,并且在未来的研究中,移植后护理的健康结果将得到改善,成本节约也将得到证明。
国际注册报告标识符(IRRID):PRR1 - 10.2196/13420。